Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Asset Utilization Ratio of 0.48 for Q1 2026, up 52.63% year-over-year from 0.32 in Q1 2025, and up 0.64% quarter-over-quarter from 0.48 in Q4 2025.
Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026) Analysis & Trends
Collegium Pharmaceutical's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.48 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 52.63% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (up 52.63% YoY), while the FY2025 annual figure was 0.47, up 4.5% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.48, up from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.53 in Q2 2024, with the low at 0.26 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 0.45 (2024), against an average of 0.41.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio plunged 45.7% in 2022, then surged 73.3% in 2023.
- Collegium Pharmaceutical's Asset Utilization Ratio stood at 0.4 in 2022, then increased by 22.11% to 0.49 in 2023, then slumped by 39.58% to 0.3 in 2024, then soared by 62.07% to 0.48 in 2025, then grew by 0.64% to 0.48 in 2026.
- Business Quant data shows COLL's Asset Utilization Ratio at 0.48 in Q1 2026, 0.48 in Q4 2025, and 0.38 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | 0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.48 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.38 |
| Jun 30, 2025 | 0.35 |
| Mar 31, 2025 | 0.32 |
| Dec 31, 2024 | 0.30 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.45 |
| Dec 31, 2022 | 0.40 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 0.45 |